NovaBay Pharmaceuticals Inc (NYSE MKT LLC:NBY)

0.59
Delayed Data
As of Mar 03
 -0.01 / -1.67%
Today’s Change
0.42
Today|||52-Week Range
1.38
-6.35%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Operating ActivitiesNet Income / Starting Line-4.3M-5.1M-7.0M-16.0M
 
 
 
 
 
Depreciation427.0K425.0K341.0K314.0K
 
 
 
 
 
Total Other Cash Flow1.4M2.0M410.0K1.7M
 
 
 
 
 
Funds From Operations-2.5M-2.7M-6.3M-14.0M
 
 
 
 
 
Funds From/For Other Operating Expenses-4.5M472.0K252.0K-1.0M
 
 
 
 
 
Net Cash Flow - Operating Activities2.0M-3.1M-6.5M-13.0M
 
 
 
 
 
 
InvestingIncrease In Investments-2.4M-7.6M-4.9M-4.3M
 
 
 
 
 
Decrease In Investments1.5M3.0M6.4M5.9M
 
 
 
 
 
Capital Expenditures-203.0K-119.0K-148.0K-141.0K
 
 
 
 
 
Fixed Asset Disposal0.000.006.0K0.00
 
 
Net Cash Flow Investing-1.2M-4.7M1.4M1.4M
 
 
 
 
 
 
FinancingShort Term Borrowings--71.0K-71.0K0.00
 
 
 
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction-371.0K0.000.000.00
 
 
Net Proceeds Stock Sale81.0K103.0K9.5M9.3M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.004.6M0.000.00
 
 
Other Uses - Financing2.0K106.0K0.000.00
 
 
 
Net Cash Flow - Financing-292.0K4.7M9.5M9.3M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----0.000.00--
 
Net Change In Cash542.0K-3.1M4.3M-2.2M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account